Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Healthwise HoldingsHKSE:00348 -6.12% Market Cap is HK$70.88 Mil as of Aug. 12, 2026. The stock has 3 warning signs investors should review. Among 691 Healthcare Providers & Services companies, China Healthwise Holdings ranks worse than 84.95% on this metric.
China Healthwise Holdings's quarterly market cap
declined
from Dec. 2024 (HK$119.42 Mil) to Jun. 2025 (HK$53.93 Mil) but then
increased
from Jun. 2025 (HK$53.93 Mil) to Dec. 2025 (HK$104.79 Mil).
China Healthwise Holdings's annual market cap
increased
from Dec. 2023 (HK$31.59 Mil) to Dec. 2024 (HK$119.42 Mil) but then
declined
from Dec. 2024 (HK$119.42 Mil) to Dec. 2025 (HK$104.79 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. China Healthwise Holdings's Enterprise Value for Today is HK$119.01 Mil.
China Healthwise Holdings (HKSE:00348) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
China Healthwise Holdings Market Cap Related Terms
China Healthwise Holdings Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Healthwise Holdings Market Cap Competitor Comparison
For the Pharmaceutical Retailers subindustry, China Healthwise Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Healthwise Holdings Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, China Healthwise Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where China Healthwise Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Healthwise Holdings (HKSE:00348) has a Market Cap of HK$70.88 Mil as of Aug. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on China Healthwise Holdings and its competitors. According to the industry distribution chart, China Healthwise Holdings ranks #587 out of 691 companies in the Healthcare Providers & Services industry, placing it in the top 84.9%.
Is China Healthwise Holdings' Market Cap too high?
China Healthwise Holdings' current Market Cap is HK$70.88 Mil. Based on the distribution chart, China Healthwise Holdings ranks #587 out of 691 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does China Healthwise Holdings' Market Cap compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, China Healthwise Holdings ranks #587 out of 691 companies for Market Cap. This places China Healthwise Holdings in the lower half of its industry. The industry median Market Cap is 104.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 104.85, based on 691 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on China Healthwise Holdings and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 104.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Healthwise Holdings's current Market Cap is HK$70.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Healthwise Holdings stock overvalued right now?
Based on GuruFocus' analysis, China Healthwise Holdings (HKSE:00348) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.06, compared to a current price of HK$0.09 — trading 53.3% above its estimated fair value. The current Market Cap is HK$70.88 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For China Healthwise Holdings (HKSE:00348), the current Market Cap is HK$70.88 Mil as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which includes, pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00348 has been successfully added to your 
